2015
DOI: 10.1016/j.carbpol.2014.09.012
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory effects of orally administered glucosamine oligomer in an experimental model of inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(34 citation statements)
references
References 34 publications
0
34
0
Order By: Relevance
“…In the cardiovascular system, O-GlcNAc modulates cardiac and vascular contractility and remodeling as well as inflammation-related processes (da Costa et al, 2018;Kronlage et al, 2019). Glucosamine, which increases O-GlcNAc-modified proteins, reduces the levels of circulating pro-inflammatory cytokines, including TNF-α and IL-6 (Azuma et al, 2015) and attenuates LPS-induced activation of NF-κB in RAW264.7 macrophages (Shin et al, 2013). Glucosamine also reduces vascular expression of pro-inflammatory mediators, inhibiting acute inflammatory responses and neointimal layer formation following balloon catheter injury of the carotid artery in ovariectomized rats (Xing et al, 2008), indicating that O-GlcNAc has anti-inflammatory and vasoprotective actions.…”
Section: Introductionmentioning
confidence: 99%
“…In the cardiovascular system, O-GlcNAc modulates cardiac and vascular contractility and remodeling as well as inflammation-related processes (da Costa et al, 2018;Kronlage et al, 2019). Glucosamine, which increases O-GlcNAc-modified proteins, reduces the levels of circulating pro-inflammatory cytokines, including TNF-α and IL-6 (Azuma et al, 2015) and attenuates LPS-induced activation of NF-κB in RAW264.7 macrophages (Shin et al, 2013). Glucosamine also reduces vascular expression of pro-inflammatory mediators, inhibiting acute inflammatory responses and neointimal layer formation following balloon catheter injury of the carotid artery in ovariectomized rats (Xing et al, 2008), indicating that O-GlcNAc has anti-inflammatory and vasoprotective actions.…”
Section: Introductionmentioning
confidence: 99%
“…Derived from the hydrolysis of chitosan, the chitooligosaccharides have several biofunctional properties, including antiinflammatory , prebiotic , antimicrobial , antitumor , and immunopotentiating effects . Therefore, the nutraceutical and medical industries have given special attention to the production of oligosaccharides from chitosan .…”
Section: Introductionmentioning
confidence: 99%
“…A recent report showed similar suppressive effects on the levels of serum tumor necrosis factor-α (TNF-α), IL-6 concentrations, serum IL-10, transforming growth factor-β, and IL-2 thorough oral administration of GlcNAc and GlcN in an experimental of rheumatoid arthritis model (Azuma et al, 2012). Moreover, oral administration of Shahidi et al Utilization of marine by-products for the recovery of value-added products COS inhibited colon shortening and tissue injury by suppressing myeloperoxidase activation in inflammatory cells, reducing serum levels of pro-inflammatory cytokines tumor necrosis factor-α and IL-6, and prolonged survival time, as well as inhibiting the activation of nuclear factor-kappa B, cyclooxygenase-2, and inducible nitric oxide synthase, in mice IBD (inflammatory bowel disease) model (Azuma et al, 2015c). Due to the inconsistent clinical data, difficulties in producing a structurally consistent product, the requirement of relatively high dosages for efficacy, and competition from fiber products with FDA health claims such as oats, bran, psyllium fiber, soy protein and phytosterol esters, chitosan is not widely used as a functional ingredient in North America (Hayes et al, 2008a).…”
Section: Application In Functional Foods/nutraceuticalmentioning
confidence: 99%